Gentiva Health Services Given Hold Rating at Deutsche Bank (GTIV)
Gentiva Health Services (NASDAQ:GTIV)‘s stock had its “hold” rating reiterated by equities research analysts at Deutsche Bank in a research note issued to investors on Friday. They currently have a $17.25 target price on the stock, up from their previous target price of $14.50. Deutsche Bank’s target price suggests a potential upside of 11.51% from the company’s current price.
Gentiva Health Services (NASDAQ:GTIV) traded up 13.12% on Friday, hitting $17.50. The stock had a trading volume of 770,864 shares. Gentiva Health Services has a 52 week low of $7.35 and a 52 week high of $16.50. The stock has a 50-day moving average of $14.87 and a 200-day moving average of $11.35. The company’s market cap is $644.7 million.
Gentiva Health Services (NASDAQ:GTIV) last announced its earnings results on Wednesday, May 7th. The company reported $0.13 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.11 by $0.02. The company had revenue of $487.50 million for the quarter, compared to the consensus estimate of $491.51 million. During the same quarter last year, the company posted $0.23 earnings per share. Gentiva Health Services’s revenue was up 17.3% compared to the same quarter last year. Analysts expect that Gentiva Health Services will post $0.91 EPS for the current fiscal year.
Other equities research analysts have also recently issued reports about the stock. Analysts at Zacks upgraded shares of Gentiva Health Services from a “neutral” rating to an “outperform” rating in a research note on Wednesday. They now have a $19.00 price target on the stock. Separately, analysts at CRT Capital downgraded shares of Gentiva Health Services from a “buy” rating to a “fair value” rating in a research note on Tuesday, June 24th. They now have a $16.00 price target on the stock. Finally, analysts at Piper Jaffray downgraded shares of Gentiva Health Services from an “overweight” rating to a “neutral” rating in a research note on Wednesday, May 21st. They now have a $14.00 price target on the stock, up previously from $11.00. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and two have given a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus target price of $15.61.
Gentiva Health Services, Inc (NASDAQ:GTIV) is engaged in providing home health services and hospice services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.